Weinberg Laurence, Faulkner Matthew, Tan Chong O, Liu Daniel H, Tay Stanley, Nikfarjam Mehrdad, Peyton Philip, Story David
Anesthesiologist, Department of Anesthesiology, Austin Hospital, Melbourne, Victoria, Australia.
BMC Res Notes. 2014 Jun 10;7:356. doi: 10.1186/1756-0500-7-356.
Routine fluid prescription is common practice amongst anesthesiologists caring for patients undergoing colonoscopy. However there is limited information about routine procedural fluid prescription practices of anesthesiologists in this setting. Routine fluid administration may also have important pharmaco-economic implications for the health care budget. Therefore we performed a prospective observational study assessing the fluid prescription practices of anesthesiologists caring for patients undergoing elective colonoscopy.
With Institutional Review Board approval, adult patients receiving procedural fluid intervention during elective colonoscopy were included.
size of intravenous cannula inserted, volumes of fluid administered, adverse events, procedure duration, and pharmaco-economic costs associated with fluid prescription. Anesthesiologists and gastroenterologists were blinded to the study.
We collected data on 289 patients who received fluid prescription by their attending anesthesiologist. Median patient age: 48 yrs (range 18-83), gender: 174 (60%) female; median duration of procedure: 24 minutes (range 12-48). Cannula size: 181 (63%) patients received a 22G cannula or smaller. Median volume of fluid administered during the colonoscopy was 325 ml (range 0 to 1000 ml). Median duration of the procedure: 25 minutes (range 12 to 48 minutes). Median volume of fluid administered in the post anaesthesia recovery unit: 450 ml (range 0 to 1000 ml). Fifteen patients (5%) became hypotensive during the procedure and two patients (<1%) developed hypotension in the PACU. There was no difference in the median fluid requirements between patients with hypotension and those without. Fluid volumes were strongly associated with increasing cannula diameter (p = 0.0001), however there was no association between fluid volumes administered and vasopressor use, peri-procedural adverse events, or procedure duration. At our institution fluid therapy currently cost about AUD$4.90 per patient: 1 L crystalloid $1.18 and fluid delivery set $3.77 Our institution performs over 9000 endoscopic procedures annually with fluid therapy costing about $45,000/year.
Routine fluid prescription by anesthesiologists managing patients undergoing colonoscopy was ineffective with low actual fluid volumes delivered during the procedure. There was no association between volumes of fluid delivered and procedural hypotension, adverse events, or procedure duration. Anesthesiologists should question the clinical and pharmaco-economic value of routine fluid administration for patients undergoing elective endoscopy.
在为接受结肠镜检查的患者提供护理的麻醉医生中,常规液体处方是常见的做法。然而,在这种情况下,关于麻醉医生常规手术液体处方做法的信息有限。常规液体给药对医疗保健预算也可能有重要的药物经济学影响。因此,我们进行了一项前瞻性观察研究,评估为接受择期结肠镜检查的患者提供护理的麻醉医生的液体处方做法。
经机构审查委员会批准,纳入在择期结肠镜检查期间接受手术液体干预的成年患者。
插入的静脉套管尺寸、给予的液体量、不良事件、手术持续时间以及与液体处方相关的药物经济学成本。麻醉医生和胃肠病医生对该研究不知情。
我们收集了289例由主治麻醉医生开具液体处方的患者的数据。患者中位年龄:48岁(范围18 - 83岁),性别:174例(60%)为女性;中位手术持续时间:24分钟(范围12 - 48分钟)。套管尺寸:181例(63%)患者接受了22G或更小的套管。结肠镜检查期间给予的液体中位体积为325毫升(范围0至1000毫升)。手术中位持续时间:25分钟(范围12至48分钟)。麻醉后恢复室给予的液体中位体积:450毫升(范围0至1000毫升)。15例患者(5%)在手术期间出现低血压,2例患者(<1%)在麻醉后护理单元发生低血压。低血压患者和未发生低血压患者的液体需求中位数无差异。液体量与套管直径增加密切相关(p = 0.0001),然而给予的液体量与血管升压药使用、围手术期不良事件或手术持续时间之间无关联。在我们机构,目前液体治疗每位患者的成本约为4.90澳元:1升晶体液1.18澳元,输液器3.77澳元。我们机构每年进行超过9000例内镜手术,液体治疗费用约为每年45,000澳元。
管理接受结肠镜检查患者的麻醉医生的常规液体处方效果不佳,手术期间实际给予的液体量较低。给予的液体量与手术期间低血压、不良事件或手术持续时间之间无关联。麻醉医生应质疑为接受择期内镜检查的患者进行常规液体给药的临床和药物经济学价值。